{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-018922","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2025-10-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.220750+00:00","generated_at":"2026-05-17T02:42:09.290638+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"medium","headline":"Palisade Bio terminates phantom equity plan; unvested awards for CEO, CMO, and SVP of Finance cancelled","bullets":["Phantom Unit Plan adopted Sept 4, 2025 terminated Oct 22, 2025.","Unvested Phantom Units for CEO J.D. Finley, CMO Mitchell Jones, SVP Finance Ryker Willie cancelled for no consideration.","No specific number of units or value disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-018922","json":"https://secwatch.observer/filing/0001493152-25-018922.json","markdown":"https://secwatch.observer/filing/0001493152-25-018922.md","text":"https://secwatch.observer/filing/0001493152-25-018922.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225018922/0001493152-25-018922-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225018922/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:42:09.290638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}